Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial

BACKGROUND AND AIM: Recurrent wheezing is often triggered by viral respiratory infections. The aims of our study were: i) to evaluate whether the addition of a nutraceutical (Leucodif®), could improve the efficacy of montelukast or inhaled steroids (ICS) compared to the single treatment; ii) to veri...

Descripción completa

Detalles Bibliográficos
Autores principales: Parisi, Giuseppe Fabio, Manti, Sara, Papale, Maria, Giallongo, Alessandro, Indolfi, Cristiana, Miraglia del Giudice, Michele, Salpietro, Carmelo, Licari, Amelia, Marseglia, Gian Luigi, Leonardi, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2022
Materias:
Original Investigations/Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171851/
https://www.ncbi.nlm.nih.gov/pubmed/35546018
http://dx.doi.org/10.23750/abm.v93i2.11958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171851/
https://www.ncbi.nlm.nih.gov/pubmed/35546018
http://dx.doi.org/10.23750/abm.v93i2.11958

Ejemplares similares